Titan Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TTNP and other ETFs, options, and stocks.

About TTNP

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.

CEO

Weei Jye Chay

CEOWeei Jye Chay

Employees

—

Employees—

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

1992

Founded1992

Employees

—

Employees—

TTNP Key Statistics

Market cap

3.38M

Market cap3.38M

Price-Earnings ratio

-0.71

Price-Earnings ratio-0.71

Dividend yield

—

Dividend yield—

Average volume

5.73K

Average volume5.73K

High today

$3.79

High today$3.79

Low today

$3.63

Low today$3.63

Open price

$3.65

Open price$3.65

Volume

8.65K

Volume8.65K

52 Week high

$14.80

52 Week high$14.80

52 Week low

$3.03

52 Week low$3.03

Titan Pharmaceuticals

Why Robinhood?

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. Show more

TTNP Key Statistics

Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.